ArticleOncoimmunology2020

Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors.

Sang Eun Won et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.